Related Experiment Video
Updated: May 8, 2026

09:49
Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
Published on: July 5, 2019
TMPRSS2-ERG Fusion Identified by Comprehensive Genomic Profiling Reveals Prostatic Origin in Cancer of Unknown
Koji Hikino1, Wataru Naito2, Shinichi Teshima2
1Department of Clinical Oncology, Shonan Kamakura General Hospital, Kamakura, JPN.
Cureus
|May 7, 2026
Summary
Comprehensive genomic profiling aids in identifying the origin of cancer of unknown primary (CUP). This approach detected a TMPRSS2-ERG fusion, confirming prostate cancer in a patient with metastatic disease.
Area of Science:
- Oncology
- Genomics
- Pathology
Background:
- Cancer of unknown primary (CUP) presents diagnostic challenges, with limited therapeutic options for unfavorable-risk patients.
- Empirical chemotherapy in CUP often leads to poor patient outcomes.
- Comprehensive genomic profiling (CGP) is increasingly used for advanced/rare solid tumors.

